Cytochrome C oxidase III interacts with hepatitis B virus X protein in vivo by yeast two-hybrid system

World Journal of Gastroenterology

Volumn 10, Issue 19, 2004, Pages 2805-2808

  Li, Dan ^a   Wang, Xiao Zhong ^b   Yu, Jie Ping ^a   Chen, Zhi Xin ^b   Huang, Yue Hong ^b   Tao, Qi Min ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME C OXIDASE; DNA FRAGMENT; PROTEIN X; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA LIBRARY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC SCREENING; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL CARCINOMA; MOLECULAR INTERACTION; NONHUMAN; POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; TWO HYBRID SYSTEM; WESTERN BLOTTING; YEAST CELL;

EID: 4644359695     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i19.2805     Document Type: Article

References (36)

1. Su Q, Schroder CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998; 27: 1109-1120
2. Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M. Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002; 62 (Suppl 1): 29-37
3. Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene 2001; 20: 3620-3628
4. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000; 62: 151-158
5. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999; 18: 4848-4859
6. Natoli G, Avantaggiati ML, Chirillo P, Puri PL, Ianni A, Balsano C, Levrero M. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 1994; 9: 2837-2843
7. Cao XY, Liu J, Lian ZR, Clayton M, Hu JL, Zhu MH, Fan DM, Feitelson M. Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver. World J Gastroenterol 2001; 7: 579-582
8. Shamay M, Barak O, Doitsh G, Ben-Dor I, Shaul Y. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem 2002; 277: 9982-9988
9. Yeh CT. Hepatitis B virus X protein: searching for a role in hepatocarcinogenesis. J Gastroenterol Hepatol 2000; 15: 339-341
10. Gietz RD, Triggs-Raine B, Robbins A, Graham KC, Woods RA. Identification of proteins that interact with a protein of interest: applications of the yeast two-hybrid system. Mol Cell Biochem 1997; 172: 67-69
11. Tarn C, Bilodeau ML, Hullinger RL, Andrisani OM. Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines. J Biol Chem 1999; 274: 2327-2336
12. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651-660
13. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320
14. Cheong JH, Yi M, Lin Y, Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 1995; 14: 143-150
15. Haviv I, Matza Y, Shaul Y. pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants. Genes Dev 1998; 12: 1217-1226
16. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991; 252: 842-844
17. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G. Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol 1996; 70: 641-646
18. Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E. The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein. J Biol Chem 1997; 272: 16482-16489
19. Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J Biol Chem 2001; 276: 8328-8340
20. Arbuthnot P, Capovilla A, Kew M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 2000; 15: 357-368
21. Rahmani Z, Huh KW, Lasher R, Siddiqui A. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 2000; 74: 2840-2846
22. Takada S, Shirakata Y, Kaneniwa N, Koike K. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene 1999; 18: 6965-6973
23. Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature 1989; 340: 245-246,
24. Bartel PL, Fields S. Analyzing protein-protein interactions using two-hybrid system. Methods Enzymol 1995; 254: 241-263
25. Lenka N, Vijayasarathy C, Mullick J, Avadhani NG. Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog Nucleic Acid Res Mol Biol 1998; 61: 309-344
26. Maurer I, Zierz S, Moller HJ. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000; 21: 455-462
27. Quigley AF, Kapsa RM, Esmore D, Hale G, Byrne E. Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy. J Card Fail 2000; 6: 47-55
28. Muller-Hocker J, Muntau A, Schafer S, Jaksch M, Staudt F, Pongratz D, Taanman JM. Depletion of mitochondrial DNA in the liver of an infant with neonatal giant cell hepatitis. Hum Pathol 2002; 33: 247-253
29. von Kleist-Retzow JC, Vial E, Chantrel-Groussard K, Rotig A, Munnich A, Rustin P, Taanman JW. Biochemical, genetic and immunoblot analyses of 17 patients with an isolated cytochrome c oxidase deficiency. Biochim Biophys Acta 1999; 1455: 35-44
30. Aguilera I, Garcia-Lozano JR, Munoz A, Arenas J, Campos Y, Chinchon I, Roldan AN, Bautista J. Mitochondrial DNA point mutation in the COI gene in a patient with McArdle's disease. J Neurol Sci 2001; 192: 81-84
31. Chandra D, Liu JW, Tang DG. Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J Biol Chem 2002; 277: 50842-50854
32. Valgimigli M, Valgimigli L, Trere D, Gaiani S, Pedulli GF, Gramantieri L, Bolondi L. Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation. Free Radic Res 2002; 36: 939-948
33. Kuo KW, Yang PY, Huang YS, Shieh DZ. Variations in gene expression and genomic stability of human hepatoma cells integrated with hepatitis B virus DNA. Biochem Mol Biol Int 1998; 44: 1133-1140
34. Li J, Xu Z, Zheng Y, Johnson DL, Ou JH. Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J Virol 2002; 76: 5875-5881
35. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001; 21: 7721-7730
36. Cogswell PC, Kashatus DF, Keifer JA, Guttridge DC, Reuther JY, Bristow C, Roy S, Nicholson DW, Baldwin AS Jr. NF-kappaB and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappaB. J Biol Chem 2003; 278: 2963-2968